Skip to search formSkip to main contentSkip to account menu

levosemotiadil

Known as: (-)-(S)-2-(5-Methoxy-2-(3-(Methyl(2-(3,4-(Methylenedioxy)Phenoxy)Ethyl)Amino)Propoxy)Phenyl)-4-Methyl-2H-1,4-Benzothiazin-3(4H)-One 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sesamodil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Combined Sodium and Calcium Channel Blockade in Prevention of Lethal Arrhythmias
Anti-arrhythmic compounds with multiple actions reduce arrhythmic death risk in post–myocardial infarction (MI) patients. Sudden… 
Review
2001
Review
2001
Application of High-Performance Frontal Analysis to Enantioselective Studies on Drug - Plasma Protein Binding
This review article demonstrates the applicability of high-performance frontal analysis (HPFA) to the enantioselective drug - p… 
1999
1999
Binding study of semotiadil and levosemotiadil with alpha(1)-acid glycoprotein using high-performance frontal analysis.
High-performance frontal analysis (HPFA) was used to investigate the binding properties of human alpha(1)-acid glycoprotein (AGP… 
1997
1997
Enantioselective local disposition of semotiadil (R-enantiomer) and levosemotiadil (S-enantiomer) in perfused rat liver.
The enantioselective local disposition of semotiadil (R-enantiomer) and levosemotiadil (S-enantiomer) in rat liver was… 
1997
1997
Enantioselective protein binding of semotiadil and levosemotiadil determined by high-performance frontal analysis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)